In the Spotlight-December 2004

The collaboration will utilize Genesis’ proprietary AI platform, initially focusing on targets selected by Incyte.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The AI co-scientist is a multi-agent AI system that can work as a virtual scientific collaborator.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

In seeking a data-driven approach to efficient drug development, MMS aims to enhance its capabilities in advanced clinical trial design, innovative statistics, and data science with the acquisition.

This site was previously the beneficiary of a €7.3 million (US$7.6 million) investment, made in 2022, earmarked for the production of HPAPIs to treat cancer.